InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Meier Richard A, 首席财务官. Insider active across 3 companies, notably Biomarin Pharmaceutical INC. Aggregated, 15 reports have been published. History available since 6 May 2021. The latest transaction was disclosed on 20 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Meier Richard A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
6,650 股0Common StockSEC:0001048477-25-000076:0
6,600 股@ US$63.1020.4% 占其流量Common StockSEC:0001048477-24-000116:0
7,080 股0Common StockSEC:0001048477-24-000108:0
3,000 股0Common StockSEC:0001048477-24-000004:0
4,190 股0Common StockSEC:0001209191-23-031975:0
8,500 股@ US$67.8128.2% 占其流量Common StockSEC:0001209191-23-030368:0
4,980 股0Common StockSEC:0001567619-22-011798:0
57,230 股@ US$28.2583.7% 占其流量Common StockSEC:0001562180-22-004076:0
8,500 股@ US$37.460.0027% mcap31.5% 占其流量Common StockSEC:0001567619-22-009496:0
36,738 股0Common StockSEC:0001562180-22-001159:0
6,346 股@ US$26.93888.9% 占其流量Common StockSEC:0001562180-21-007368:0
5,120 股0Common StockSEC:0001567619-21-011316:0
15,000 股@ US$26.4921.3% 占其流量Common StockSEC:0001567619-21-009351:0
10,213 股Common StockSEC:0000075252-16-000116:0
5,301 股Common StockSEC:0000075252-16-000116:1
15 条申报中的 15 条
About Meier Richard A
Richard A. Meier is a Director and Executive Vice President at BIOMARIN PHARMACEUTICAL INC and Intersect ENT, Inc. He oversees the financial operations and strategy of the companies. Meier is responsible for managing financial resources and producing financial reports. His expertise in finance is essential for ensuring the growth and profitability of the companies.
